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A central dip in macular pigment (MP) has shown to be more prevalent with 
age, in AMD patients, and in smokers. We investigated clinical and genetic 
biomarkers in non‐smoking children of AMD parents (n = 131) over 40 years 
of age without AMD pathology in relation to their MP spatial profile. MP peak 
and volume were obtained with ARIS (Visual Pathways, Inc, Prescott, AZ 
USA) while spatial profiles for both eyes were classified visually and 
objectively. We explored risk factors including serum carotenoids and in‐vivo 
skin carotenoids, and cardiovascular biomarkers including omega‐3 fatty 
acids EPA and DHA, methylenetetrahydrofolate reductase C677T and 
A1298C in this well‐nourished Caucasian study group. Objectively, a central 
dip appeared more prevalent in children of AMD patients (41%) when 
compared to a healthy population. Those with central dip showed increased 
mean MP peak and volume, decreased serum L, Z, EPA and DHA, and 
decreased skin carotenoids in comparison to no dip. Identifying biomarkers in 
children genetically susceptible to AMD and introducing lifestyle changes such 
as nutrient repletion could provide invaluable advice to those associated with 
increased risk of AMD. 
